Levomilnacipran Hydrochloride
5 NDCs across 1 manufacturer|0 Generic,5 Brand
Levomilnacipran Hydrochloride is used to treat major depressive disorder, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Jul 25, 2013, and the first generic was approved Feb 4, 2019. FDA's Orange Book lists 8 AB-rated (therapeutically equivalent) products for this ingredient.
Levomilnacipran Hydrochloride is available as 5 NDCs from 1 manufacturer (0 generic, 5 brand), with NADAC prices from $17.59 to $17.61 per EA — a 0% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
5
0G / 5B
Manufacturers
1
competing in market
Price Spread
$17.59 – $17.61
per EA
7d Activity
avg -0.0% WoW · of 5 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Allergan, Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Serotonin and Norepinephrine Reuptake Inhibitor class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
1 manufacturer producing LEVOMILNACIPRAN HYDROCHLORIDE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
FETZIMA ER 40 MG CAPSULE | $17.6112 per EA | -0.05% |
FETZIMA 20-40 MG TITRATION PAK | $17.6066 per EA | — |
FETZIMA ER 20 MG CAPSULE | $17.5973 per EA | +0.03% |
FETZIMA ER 80 MG CAPSULE | $17.5875 per EA | -0.01% |
FETZIMA ER 120 MG CAPSULE | $17.5871 per EA | +0.01% |
Frequently Asked Questions
What is Levomilnacipran Hydrochloride used to treat?
Levomilnacipran Hydrochloride is used to treat major depressive disorder, per the National Library of Medicine's MED-RT classification.
When did Levomilnacipran Hydrochloride become available as a generic?
FDA approved the first generic Levomilnacipran Hydrochloride (ANDA) on Feb 4, 2019. The Orange Book currently lists 8 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How many Levomilnacipran Hydrochloride products are on the market?
The Levomilnacipran Hydrochloride drug market contains 5 NDCs from 1 manufacturer — 0 generic and 5 brand products.
What is the price range for Levomilnacipran Hydrochloride?
NADAC reference prices for Levomilnacipran Hydrochloride range from $17.5871 to $17.6112 per EA — a 0% difference between cheapest and most expensive.
Which manufacturers make Levomilnacipran Hydrochloride?
1 manufacturer lists Levomilnacipran Hydrochloride in NADAC. Ranked by number of NDCs, the largest are Allergan, Inc. (5).
How has the price of Levomilnacipran Hydrochloride changed recently?
Over the past 7 days, 2 Levomilnacipran Hydrochloride NDCs rose and 2 fell, with a market-wide average change of -0.0%.